 |
|
|
 |
| APRIL
9,
2009 | ISSUE NUMBER 96 VOL 3 |
 |
Strategy
Pfizer Begins Wyeth Integration with New Research Structure
Just two months after the purchase of Wyeth, Pfizer breaks its research division into two—one for large molecules and vaccines, and another for small molecules—with Wyeth and Pfizer execs at the helms.
>>MORE
Warning Letters
Pharma Companies Hit With Warnings for Search Marketing
FDA is cracking down on content in search engine advertisements. The argument is that there is a serious deficiency of risk information in the tiny link ads that appear on search ads. With pharma already wary of marketing online, will FDA’s tactic hurt future Web campaigns?
>>MORE
Legal
Post-Employment Restrictive Covenants
A company’s trade secrets and the goodwill it has developed can mean the difference between a blockbuster and a failure. Here’s what you should know and do to properly negotiate post-employment agreements.
>>MORE

Sales Management
Goodbye, Willy Loman
The days of pharma sales reps going office-to-office with samples and brochures are done. These days, they need to turn their attention to payers, pharmacists, and consumers.
>>MORE
Marketing
Putting Predictive Market Research to the Test
There’s a temptation for companies to view predictive markets as a silver bullet. Can crowds actually do a better job than "experts," or is that viewpoint more of a fad than a foundation for accurate future forecasting?
>>MORE
Podcasts
Celebrating Women of The Year— Lynn O’Connor Vos
Live life on your toes, not your heels, says Lynn O’Connor Vos, CEO of Grey Healthcare Group, and you’ll always be ready for opportunities.
>>MORE
|
 |
| Epocrates appointed Rose Crane CEO. // Double Helix Consulting US appointed Ann Stuchiner to vice president. // Solara promoted Trudy Chiavelli to senior account executive. // Valeant Pharmaceuticals appointed Steve Stefano to its board of directors. // Endo Pharmaceuticals appointed Nancy J. Hutson to its board of directors. // Merkle appointed Jeff Wiltrout to vice president and client group leader. // Health Decisions appointed Rich Podurgal as chief human resources officer. // Intouch Solutions appointed Mary Doherty as vice president of client services and Steve Wright as senior director of development. // Fleet Laboratories named Jeffrey Rowan president and CEO. // HealthWorldWeb appointed Michael L. Millenson and J.D. Kleinke to the board of advisors. // Kelly McNulty has joined International Medical News Group as national sales manager at Elsevier Oncology. // MicroMass Communications promoted Kim Levy to senior vice president. // MedAccess promoted Leana Wood to executive vice president and its parent company Access Communications, advanced Seth Gordon to executive vice president. |
Advertisment
Protecting Sensitive Information in Life Sciences Organizations
Because of their investment in intellectual property and the clinical trial information they generate, life sciences companies face greater security risks than other companies. This paper explores common business processes that put companies at risk and ways companies protect themselves.
Read more... |
May 18–21 BIO International Convention, Atlanta, GA
May 27–28 4th Forum on Patient Reported Outcomes (PRO), Alexandria, VA
June 5 American Cancer Society’s "The Magic of Hope" Luncheon, New Brunswick, NJ
June 21–25 Drug Information Association 45th Annual Meeting, San Diego, CA
July 30 –31 CBI’s 4th Clinical Supply Chain Management Conference, Princeton, NJ |
Advertisment
BIO – Be There!
Join 20,000 executives, investors, scientists, policy makers and journalists from around the world in Atlanta, Georgia, May 18–21, for the 2009 BIO International Convention. Access the expert knowledge and resources you need to meet the challenges of today’s dynamic economy and to strengthen your business for tomorrow. Discover breakthrough innovations that are healing, fueling and feeding the world.
Register today. |
April 21 Understanding the Complexities of State Licensing and VAWD,
11pm ET
Sponsored By Cegedim Dendrite
May 12 Transforming Sales & Marketing Given Today's Pharma Realities: A New Model for Success,
1pm ET
Sponsored By IMS Health |
Advertisment
From the editors of Pharmaceutical Executive: Contract Management Poll!
Drawing to win a HDTV and a Blu-Ray Disc player, take our 6-8 minute, confidential poll today.
Just click here to take our Poll today! |
|
|
 |
 |
| Would
splitting FDA into two divisions—one for
food and one for healthcare—speed up the
drug approval process? |
|
|
|
You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.To
ensure delivery to your Inbox, please add %%email.list%% to your
address book. If you need help doing this, click
here.
Advanstar
Communications provides certain customer contact data (such as customers'
names, addresses, phone numbers and e-mail addresses) to third parties
who wish to promote relevant products, services and other opportunities
which may be of interest to you. If you do not want Advanstar Communications
to make your contact information available to third parties for
marketing purposes, simply call (toll free) 1-866-529-2922 at any
time, or fax us at 1-218-740-6417. Outside the U.S., please phone
1-218-740-6395. Contact us by mail at Advanstar Communications Inc.,
131 West First St., Duluth, MN 55802-2065, USA. |
|